Blog

ESACT Frontiers Retreat in Lyon 2016 – A Great Unusual Scientific Meeting

Between the 20th and the 22nd October, I had the opportunity to attend  the 1st ESACT Frontiers Retreat 2016, taking place in Lyon. Citing words from the organizing committee, this was a non conventional scientific meeting “dedicated to early career scientists working in the cell culture technology field and aimed to engage the next generation…
Read more

miR-acle Grow: Improving CHO cell Growth by miRNA Dysregulation

The “CHO group” here in NICB is a sizable collection of young researchers, incorporating people with a wide variety of cultural and academic backgrounds. Collectively, we effort to tackle many real challenges facing the biopharmaceutical industry today. Some members such as myself, use targeted genetic engineering approaches to improve Chinese Hamster Ovary (CHO) cell characteristics,…
Read more

eCHO Systems – Enhancing the CHO cell factory using Systems Biology

On the 13-14th of September,  the 2nd Annual Meeting for the eCHO Systems Innovative Training Network (ITN)  took place in Vienna. The members of the consortium had the opportunity to meet together with the Scientific Advisory board and the Principal Investigators to discuss the progress made so far and share their future plans for the…
Read more

Blocking The Roads To Resistance In Breast Cancer

From explaining your research to your family, friends or even funding bodies, the ability to communicate your research to the general public is an extremely important skill for scientists. My PhD project is investigating the ways in which breast cancer cells respond and adapt to current treatments and recently I produced an animated video to…
Read more

Leachables from disposable bioreactors: Sucking the blood from Biopharma

The future of biopharmaceutical manufacturing platforms is to implement the use of small-scale disposable single-use (SU) plastic wave-reactor bags in parallel to the commonly used 10,000 L stainless steel bioreactors. This will see the industry undergo a facelift with both large multi-billion dollar facilities and smaller, more flexible, sites being constructed with the ability to…
Read more

What is a Monoclonal Antibody?

Originally discovered by Emil Von Bering and Paul Erhlich, antibodies are proteins produced by the immune system that target a specific foreign object (antigen). They are called monoclonal Antibodies (mAbs) when they are produced by clones derived from a single parent cell. Monoclonal antibodies have a high affinity for their epitope, the specific site of…
Read more

A DRIVE towards enhanced Diabetes Treatment

The DRIVE (Diabetes Reversing Implants with enhanced Viability and long-term Efficacy) consortium met recently in Venice Italy for its second general assembly to discuss progress, challenges and plans going forward for achieving their goal of improved Diabetes treatment. Diabetes type 1 is a chronic condition characterised by loss of insulin-producing pancreatic β-cells and an inability…
Read more

The First Cornea-Limbal Stem Transplant in Ireland

On Tuesday morning 07.06.2016, Mr. William Power, Consultant Ophthalmic Surgeon, conducted the very first cornea-limbal stem cell transplant in Ireland, at the Royal Victoria Eye & Ear Hospital, an event that was covered by RTE. Mr. Patrick Godfrey of Co Tipperary underwent the procedure during an hour-long operation in an attempt to restore his deteriorating…
Read more